Literature DB >> 19921850

Glutaminyl cyclases display significant catalytic proficiency for glutamyl substrates.

Franziska Seifert1, Katrin Schulz, Birgit Koch, Susanne Manhart, Hans-Ulrich Demuth, Stephan Schilling.   

Abstract

N-Terminal glutaminyl and glutamyl residues of peptides and proteins tend to form pyroglutamic acid (pGlu) by intramolecular cylization. The rate constants for spontaneous cyclization of glutamine (10(-6) s(-1)) and glutamic acid (10(-9) s(-1)) in aqueous solution differ by approximately 3 orders of magnitude at pH 6.5. Glutaminyl cyclases (QCs) from plants and mammals accelerate pGlu formation. Human QC exhibits a rate enhancement of 2.2 x 10(5) for glutamate cyclization, approximately 2 orders of magnitude lower than that of the corresponding N-terminal glutaminyl reaction. Thus, glutaminyl cyclases are enzymes with only modest specificity for cyclization of their primary glutaminyl substrates and may provide a link between glutamate cyclization and pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19921850     DOI: 10.1021/bi9018835

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

Review 1.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

2.  Pyroglutamate-Aβ 3 and 11 colocalize in amyloid plaques in Alzheimer's disease cerebral cortex with pyroglutamate-Aβ 11 forming the central core.

Authors:  Christopher P Sullivan; Eric A Berg; Rosemary Elliott-Bryant; Jordan B Fishman; Ann C McKee; Peter J Morin; Michael A Shia; Richard E Fine
Journal:  Neurosci Lett       Date:  2011-10-06       Impact factor: 3.046

3.  Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding.

Authors:  Kai-Fa Huang; Su-Sen Liaw; Wei-Lin Huang; Cho-Yun Chia; Yan-Chung Lo; Yi-Ling Chen; Andrew H-J Wang
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

4.  Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.

Authors:  Jeffrey L Frost; Kevin X Le; Holger Cynis; Elizabeth Ekpo; Martin Kleinschmidt; Roberta M Palmour; Frank R Ervin; Shikha Snigdha; Carl W Cotman; Takaomi C Saido; Robert J Vassar; Peter St George-Hyslop; Tsuneya Ikezu; Stephan Schilling; Hans-Ulrich Demuth; Cynthia A Lemere
Journal:  Am J Pathol       Date:  2013-06-07       Impact factor: 4.307

5.  Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug development.

Authors:  Stephan Schilling; Stephanie Kohlmann; Christoph Bäuscher; Reinhard Sedlmeier; Birgit Koch; Rico Eichentopf; Andreas Becker; Holger Cynis; Torsten Hoffmann; Sabine Berg; Ernst-Joachim Freyse; Stephan von Hörsten; Steffen Rossner; Sigrid Graubner; Hans-Ulrich Demuth
Journal:  J Biol Chem       Date:  2011-02-17       Impact factor: 5.157

6.  Molecular characterization of tick salivary gland glutaminyl cyclase.

Authors:  Steven W Adamson; Rebecca E Browning; Chien-Chung Chao; Robert C Bateman; Wei-Mei Ching; Shahid Karim
Journal:  Insect Biochem Mol Biol       Date:  2013-06-13       Impact factor: 4.714

7.  Production, composition, and mode of action of the painful defensive venom produced by a limacodid caterpillar, Doratifera vulnerans.

Authors:  Andrew A Walker; Samuel D Robinson; Jean-Paul V Paluzzi; David J Merritt; Samantha A Nixon; Christina I Schroeder; Jiayi Jin; Mohaddeseh Hedayati Goudarzi; Andrew C Kotze; Zoltan Dekan; Andy Sombke; Paul F Alewood; Bryan G Fry; Marc E Epstein; Irina Vetter; Glenn F King
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

8.  The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions.

Authors:  Holger Cynis; Torsten Hoffmann; Daniel Friedrich; Astrid Kehlen; Kathrin Gans; Martin Kleinschmidt; Jens-Ulrich Rahfeld; Raik Wolf; Michael Wermann; Anett Stephan; Monique Haegele; Reinhard Sedlmeier; Sigrid Graubner; Wolfgang Jagla; Anke Müller; Rico Eichentopf; Ulrich Heiser; Franziska Seifert; Paul H A Quax; Margreet R de Vries; Isabel Hesse; Daniela Trautwein; Ulrich Wollert; Sabine Berg; Ernst-Joachim Freyse; Stephan Schilling; Hans-Ulrich Demuth
Journal:  EMBO Mol Med       Date:  2011-07-20       Impact factor: 12.137

9.  Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration.

Authors:  Andreas Becker; Stephanie Kohlmann; Anca Alexandru; Wolfgang Jagla; Fabio Canneva; Christoph Bäuscher; Holger Cynis; Reinhard Sedlmeier; Sigrid Graubner; Stephan Schilling; Hans-Ulrich Demuth; Stephan von Hörsten
Journal:  BMC Neurosci       Date:  2013-10-01       Impact factor: 3.288

Review 10.  Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges.

Authors:  Holger Cynis; Jeffrey L Frost; Helen Crehan; Cynthia A Lemere
Journal:  Mol Neurodegener       Date:  2016-06-30       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.